EGFR and lung carcinoma: Studies of advanced lung cancer patients in the United States suggest that there may be SES‐based inequalities in survival,28 in the use of breakthrough palliative treatments,29 and geography‐based inequalities in the delay to initiate EGFR‐TKI treatment.30